Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Can biomarkers be used to diagnose attention deficit hyperactivity disorder? | Front Psychiatry | 2023 | 36970271 | PubTator, text mining | PubMed |
| Development and validation of a genomic nomogram based on a ceRNA network for comprehensive analysis of obstructive sleep apnea. | Front Genet | 2023 | 36968605 | PubTator, text mining | PubMed |
| Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers. | iScience | 2023 | 36968082 | PubTator, text mining | PubMed |
| Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis. | J Nanobiotechnology | 2023 | 36967397 | PubTator, text mining | PubMed |
| The function and mechanisms of action of circular RNAs in Urologic Cancer. | Mol Cancer | 2023 | 36966306 | PubTator, text mining | PubMed |
| Integrative identification of hub genes in development of atrial fibrillation related stroke. | PLoS One | 2023 | 36952494 | PubTator, text mining | PubMed |
| Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing. | Sci Rep | 2023 | 36949176 | PubTator, text mining | PubMed |
| Association of OPRM1, MIR23B, and MIR107 genetic variability with acute pain, chronic pain and adverse effects after postoperative tramadol and paracetamol treatment in breast cancer. | Radiol Oncol | 2023 | 36942908 | PubTator, text mining | PubMed |
| Integrated analysis of C3AR1 and CD163 associated with immune infiltration in intracranial aneurysms pathogenesis. | Heliyon | 2023 | 36942257 | PubTator, text mining | PubMed |
| Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. | BMC Bioinformatics | 2023 | 36935487 | PubTator, text mining | PubMed |
| Exosomal MFI2-AS1 sponge miR-107 promotes non-small cell lung cancer progression through NFAT5. | Cancer Cell Int | 2023 | 36934264 | PubTator, text mining | PubMed |
| Roles of lncRNAs in childhood cancer: Current landscape and future perspectives. | Front Oncol | 2023 | 36923440 | PubTator, text mining | PubMed |
| Therapeutic potential of ADAM10 modulation in Alzheimer's disease: a review of the current evidence. | Cell Commun Signal | 2023 | 36918870 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells. | Heliyon | 2023 | 36915498 | PubTator, text mining | PubMed |
| Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data. | Front Immunol | 2023 | 36911742 | PubTator, text mining | PubMed |
| Iron metabolism in colorectal cancer. | Front Oncol | 2023 | 36910614 | PubTator, text mining | PubMed |
| A growing understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia. | Front Cell Neurosci | 2023 | 36909280 | PubTator, text mining | PubMed |
| MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer's Disease. | Int J Mol Sci | 2023 | 36902178 | PubTator, text mining | PubMed |
| Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. | Int J Mol Sci | 2023 | 36902096 | PubTator, text mining | PubMed |
| Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. | Int J Mol Sci | 2023 | 36901717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=22